May 20, 2013 |
Baby boomers should be reviewing their retirement portfolios once a year and tweaking or re-balancing them, if necessary, says Delia Fernandez, a fee-only certified financial planner. Fernandez is the founder of Fernandez Financial Advisory in Los Alamitos. She had that suggestion and more for Marymount College math professor Patrick Webster, 63 and his wife Susie Martin, 54, who also works at Marymount. GALLERY: Bank failures that drained deposit-insurance funds The couple had managed to amass savings of more than $1 million, but they were still worried.
January 20, 2010 |
Heavy losses in real estate holdings battered 2009 investment returns at California's giant public pension fund, although the portfolio overall rose in value for the year. The California Public Employees' Retirement System earned an 11.8% return on its portfolio as global stock markets recovered from the collapse of 2008, the fund said Tuesday. The portfolio had dived 27.1% in 2008. But the gain for 2009 was far below CalPERS' internal benchmark of 21.2%, which is based on the performance of broad indexes of investments similar to what the fund owns.
April 5, 2010 |
At least one-third of Kimberly Sterling's clients have sought advice in the last year about investing in gold. The Orlando financial planner has successfully discouraged all but one from doing so. That one investor insisted on having some gold in his portfolio, she said, despite her warnings. Eventually she referred him to a gold-commodities exchange-traded fund that has done well during the metal's decade-long run-up in price. But her firm, Resource Consulting Group, still wouldn't buy in. "Our bottom line is this: Gold is a bubble now, and it is too late to get in," she said recently.
February 2, 2009 |
There doesn't appear to be a lot of philosophical or practical daylight between Joseph A. Dear, the new chief investment officer of the country's largest public pension fund, and the labor-oriented board that hired him. And he doesn't see much daylight in gloomy financial markets, either. Dear, 57, is leaving a similar post at the Washington State Investment Board to run the $177-billion portfolio at the much larger, 1.6-million-member California Public Employees' Retirement System, or CalPERS.
December 26, 2009 |
At a time when major biotech companies in California are eager for investors, Japanese pharmaceutical companies are increasingly becoming a go-to place for money to develop and sell new drugs. Japan's largest drug maker teamed up with Amylin Pharmaceuticals Inc. in San Diego last month to develop and sell an obesity drug that the companies think could eventually be worth $1 billion. In October, Japan's second-largest drug firm announced a $110-million payment to Medivation Inc. of San Francisco to develop and market a potential prostate cancer drug together in a deal that they hope could reach $655 million.